Page 6,000«..1020..5,9996,0006,0016,002..6,0106,020..»

Qik – Interview of the future of stem cell research by jpalmer715 – Video

Posted: Published on December 8th, 2012

Qik - Interview of the future of stem cell research by jpalmer715 Streamed by jpalmer715 in United States. More at qik.com Qik is the fastest way to upload videos to YouTube from your mobile phone. Find out more at qik.com.From:Jeremy PalmerViews:0 0ratingsTime:02:02More inPeople Blogs Continue reading here: Qik - Interview of the future of stem cell research by jpalmer715 - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Qik – Interview of the future of stem cell research by jpalmer715 – Video

Interview of the future of stem cell research – Video

Posted: Published on December 8th, 2012

Interview of the future of stem cell research I created this video with the YouTube Video Editor (www.youtube.comFrom:Jeremy PalmerViews:3 0ratingsTime:01:53More inPeople Blogs See the original post: Interview of the future of stem cell research - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Interview of the future of stem cell research – Video

Shawn Chavez, PhD, talks about research on selecting healthy embryos for IVF – Video

Posted: Published on December 8th, 2012

Shawn Chavez, PhD, talks about research on selecting healthy embryos for IVF During in-vitro fertilization (IVF), physicians much choose among many embryos to pick the ones that are most likely to produce a successful pregnancy and health child. Shawn Chavez, PhD, a researcher at the Stanford Institute for Stem Cell Biology and Regenerative Medicine, talks about an automated time-lapse recording system that can accurately detect which embryos are healthiest. She discusses new research showing that a parameter called "fragmentation" is important.From:institutesofmedicineViews:3 0ratingsTime:02:05More inEducation See the original post here: Shawn Chavez, PhD, talks about research on selecting healthy embryos for IVF - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Shawn Chavez, PhD, talks about research on selecting healthy embryos for IVF – Video

Twelve Days of Scott Walker’s Term – Video

Posted: Published on December 8th, 2012

Twelve Days of Scott Walker's Term (tune: The Twelve Days of Christmas lyrics: Brandon Barwick) On the 12th day of his term, Scott Walker took from us Fair voting districts The shrinking middle class Lower than average unemployment A united DNR Healthcare for the poor Wiscinsin's shining virtue Good public education HIGH SPEED RAIL! Fair union contracts Safe drinking water Stem cell research And an unarmed populace.From:Mary Ellen SchutzViews:0 0ratingsTime:03:35More inNonprofits Activism Here is the original post: Twelve Days of Scott Walker's Term - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Twelve Days of Scott Walker’s Term – Video

Support Human Embryonic Stem Cell Research – Video

Posted: Published on December 8th, 2012

Support Human Embryonic Stem Cell Research We are a group of students in WRD 111 at the University of Kentucky. This is our video supporting the use and funding of human embryos in stem cell research. We do not own any of the music or movies in this video. Link to text of Dickey-Wicker Amendment: embryo.asu.edu Link to petition to repeal the Dickey-Wicker Amendment: petitions.whitehouse.gov Link to Congressmen contact information: http://www.contactingthecongress.orgFrom:Jessica GravesViews:0 0ratingsTime:03:47More inScience Technology Visit link: Support Human Embryonic Stem Cell Research - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Support Human Embryonic Stem Cell Research – Video

German Court Decision May Strengthen International Stem Cell Corporation's Position in European Market

Posted: Published on December 8th, 2012

CARLSBAD, CA--(Marketwire - Dec 7, 2012) - International Stem Cell Corporation ( OTCQB : ISCO ) (www.internationalstemcell.com), a biotechnology company focused on the development of therapeutic products using parthenogenetic stem cells, heralds the recent decision by the German Federal Court of Justice, in the Greenpeace vs Brstle patent case, which may allow ISCO to take a leading position in the European market. This important ruling strengthens ISCO's position that parthenogenetic technology may be an acceptable method of producing banks of human pluripotent stem cell (hpSC) lines and derivatives for the commercial therapeutic markets in Europe.Under the ruling, patent restrictions will remain on other stem cell technologies, including embryonic stem cells, that require the destruction of human embryos.The ruling is especially timely in light of ISCO's recent announcement of the creation of new clinical grade human parthenogenetic stem cell lines in the United States. Leading stem cell biologist Professor Albrecht Mller, of the Center for Experimental Molecular Medicine, University of Wrzburg, Germany, comments, "Being able to patent cells and cell products is key to building a successful stem cell based biotechnology industry in Europe.We have already shown that hpSCs have tremendous potential to treat neurological diseases, and this new ruling makes … Continue reading →

Posted in Stem Cell Research | Comments Off on German Court Decision May Strengthen International Stem Cell Corporation's Position in European Market

Stem Cell Research. Donate and Save Lives. – Video

Posted: Published on December 8th, 2012

Stem Cell Research. Donate and Save Lives. Stem cell research can save lives, but aside from research, everyone can help find cures by donating to the cause and giving researches the ability to execute these objectives. Do you part and donate today. CellTherapyFoundation.OrgFrom:Jonah EvansViews:0 0ratingsTime:00:32More inNonprofits Activism Continue reading here: Stem Cell Research. Donate and Save Lives. - Video … Continue reading →

Comments Off on Stem Cell Research. Donate and Save Lives. – Video

Spectrum Pharmaceuticals Highlights 19 Abstracts at the 54th Annual Meeting of the American Society of Hematology (ASH …

Posted: Published on December 8th, 2012

HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced key presentations of clinical and scientific data at the 54th Annual Meeting of the American Society of Hematology (ASH), being held in Atlanta, Georgia, from December 8-11, 2012. The presentations include two oral presentations and 10 poster presentations for ZEVALIN (ibritumomab tiuxetan) injection for intravenous use, three poster presentations for FOLOTYN (pralatrexate injection), and four poster presentations for belinostat, a novel histone deacetylase (HDAC) inhibitor. Nearly 20 presentations at ASH will feature clinical and scientific data for Spectrums commercial products, ZEVALIN and FOLOTYN, as well as our late-stage drug candidate, belinostat, said Rajesh C. Shrotriya, M.D., Chairman, President and Chief Executive Officer of Spectrum Pharmaceuticals, Inc. The ZEVALIN-related abstracts demonstrate its use in a multitude of diverse settings and potential indications in which this product is being tested, including transplantation, its use in elderly patients, in frontline treatment and in the treatment of relapsed/refractory disease, as well as in new drug combinations. The FOLOTYN-related abstracts include presentations on new, synergistic combinations with other approved agents and in difficult-to-treat indications, such as HTLV-1-induced leukemia/lymphoma, … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off on Spectrum Pharmaceuticals Highlights 19 Abstracts at the 54th Annual Meeting of the American Society of Hematology (ASH …

Report: CA stem cell agency needs a restructuring

Posted: Published on December 8th, 2012

LOS ANGELES (AP) California has transformed into a powerhouse player in stem cell research, but the taxpayer-funded institute responsible for that needs an overhaul, a report released Thursday found. The review by the Institute of Medicine lauded the California Institute for Regenerative Medicine for making the state a leader in the field by funneling research money with an eye toward stem cell therapies. But the report found too many members of the governing board represented schools that won funding and recommended a restructuring to avoid the appearance of conflict of interest. California voters in 2004 passed Proposition 71, a state ballot initiative that created CIRM, at a time when there were federal restrictions on human embryonic stem cell research and such work was opposed by some on religious and moral grounds because embryos have to be destroyed to harvest the cells. The agency was given broad power to distribute $3 billion in bond proceeds to promising research. So far, it has awarded $1.3 billion to nearly five dozen universities that went mostly to new buildings and basic research. The team of experts that reviewed the stem-cell agency's operations did not judge the merits of individual studies because it would have … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Report: CA stem cell agency needs a restructuring

Report: Calif. stem cell agency needs overhaul

Posted: Published on December 8th, 2012

LOS ANGELES (AP) California has transformed into a major player in stem cell research, but the taxpayer-funded institute responsible has "significant deficiencies" in how research dollars are distributed, experts said Thursday. A report by the Institute of Medicine found too many members on the board of the California Institute for Regenerative Medicine represented schools that won funding and recommended a restructuring to avoid the appearance of conflict of interest. California voters in 2004 approved Proposition 71, a state ballot initiative that created CIRM, at a time when there were federal restrictions on human embryonic stem cell research and such work was opposed by some on religious and moral grounds because embryos have to be destroyed to harvest the cells. The agency was given broad power to distribute $3 billion in bond proceeds to promising research. So far, it has distributed more than $1 billion to some five dozen universities that went mostly toward investments in new buildings and basic research. The team of 13 experts that reviewed the stem-cell agency's operations did not judge the merits of individual studies because that was outside the scope of the report and it would have been too time-consuming and costly. But they raised … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Report: Calif. stem cell agency needs overhaul

Page 6,000«..1020..5,9996,0006,0016,002..6,0106,020..»